Progress on the Study of PD-L1 Detection Methods in Non-small Cell Lung Cancer / 中国肺癌杂志
Chinese Journal of Lung Cancer
; (12): 40-44, 2019.
Article
em Zh
| WPRIM
| ID: wpr-772333
Biblioteca responsável:
WPRO
ABSTRACT
PD-1/PD-L1 inhibitors play an important role in the first-line and second-line treatment of non-small cell lung cancer (NSCLC), indicating a new treatment strategy of NSCLC. Completed clinical trials have shown that effective detection of PD-L1 expression is the key to the use of immunosuppressive agents. However, the gold standard for PD-L1 detection has still lacked. In recent years, immunohistochemistry (IHC) and enzyme-linked immunosorbent assay (ELISA) have been continuously innovated, which accounts for good prospect in PD-L1 detection. The research progress of PD-L1 detection methods in NSCLC is summarized in this review.
.
Palavras-chave
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Ensaio de Imunoadsorção Enzimática
/
Imuno-Histoquímica
/
Biomarcadores Tumorais
/
Reprodutibilidade dos Testes
/
Sensibilidade e Especificidade
/
Carcinoma Pulmonar de Células não Pequenas
/
Diagnóstico
/
Antígeno B7-H1
/
Neoplasias Pulmonares
/
Metabolismo
Tipo de estudo:
Diagnostic_studies
Limite:
Humans
Idioma:
Zh
Ano de publicação:
2019
Tipo de documento:
Article